| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Geovax Labs, Inc. (GOVX) has 11 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. GOVX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 185.5K | $246.7K | - | |
| Other | 70.0K | $93.1K | - | |
| VP | 70.0K | $93.1K | - | |
| CFO | 70.0K | $93.1K | - | |
| Dir | 21.4K | $28.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 4, 2022 | McKee Kelly T. Jr. | Chief Medical Officer | Buy | 4,999 | $0.71 | $3,549.29 | New | |
| Sep 29, 2020 | Reynolds Mark | CFO | Buy | 60,184 | $5.00 | $300,920.00 | New | |
| Sep 29, 2020 | Dodd David A | President, CEO | Buy | 81,870 | $5.00 | $409,350.00 | New | |
| Sep 29, 2020 | McNally Robert T | Director | Buy | 53,925 | $5.00 | $269,625.00 | New | |
| Sep 29, 2020 | Spencer John N Jr | Director | Buy | 21,024 | $5.00 | $105,120.00 | New | |
| Sep 29, 2020 | Kollintzas Dean G | Director | Buy | 11,987 | $5.00 | $59,935.00 | New | |
| Sep 29, 2020 | Chase Randal D | Director | Buy | 16,613 | $5.00 | $83,065.00 | New | |
| May 5, 2015 | Chase Randal D | Director | Buy | 10,000 | $0.19 | $1,899.50 | +14.3% | |
| Apr 23, 2015 | Reynolds Mark | CFO | Buy | 30,000 | $0.17 | $5,215.00 | +21.7% | |
| Apr 20, 2015 | Spencer John N Jr | Director | Buy | 18,000 | $0.17 | $3,015.00 | +62.9% |